John Murphy III
business executiveMale0.0Global Dominance: 0.00%
John Murphy III is the CEO of the Association for Accessible Medicines, a trade group representing the generic and biosimilar medicine industry. He has been vocal about the potential negative impact of proposed tariffs on pharmaceutical imports, warning that they could exacerbate drug shortages and hinder the ability of generic drug manufacturers to operate in the United States.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
John Murphy III, the industry association’s CEO, expressed concerns about market support for new investments.
Drugmakers are pouring billions of dollars into new US manufacturing. It still won’t achieve all of Trump’s tariff goalsCNN·
United States· 2025-08-02
United States· 2025-08-02
John Murphy III, CEO of the Association for Accessible Medicines, warned that tariffs could amplify drug shortages concerns.
New US tariffs could make it harder to get certain generic drugsCNN·United States· 2025-04-16
United States· 2025-04-16
